Breast Cancer Highlights From ASCO 2024 [Video]

In this exclusive MedPage Today video, Adriana Kahn, MD, of the Yale Cancer Center in New Haven, Connecticut, discusses some of the top research in metastatic breast presented at the American Society of Clinical Oncology (ASCO) annual meeting.

Following is a transcript of her remarks:

I’m glad to be here at ASCO, because every year we come with lots of hopes for the future of research because we need changes for our patients with metastatic disease. Every ASCO we get excited with upcoming studies, not just the ones that are going to be performed, but most importantly results of the ones that have been performed.

And for metastatic breast cancer, we had lots of updates this year, which is exciting for all of our patients. Studies in the hormone-positive, HER2-negative metastatic breast cancers specifically are of interest because that’s the largest population that we have with metastatic disease.

And we have great updates in the first-line setting with updates on …